Research
NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Nature ·
The Brief
- A Nature journal article, titled "NAION during incretin-based therapy: an optic nerve head still adapted to hypertension", was listed in a nature.com subject feed dated 2026-11-19.
- The source provided only the title, so the article's findings beyond the title cannot be confirmed from the available material.
- The title links non-arteritic anterior ischaemic optic neuropathy (NAION) with incretin-based therapy and describes the optic nerve head as still adapted to hypertension.
Why it matters
The title ties a serious optic nerve condition, NAION, to incretin-based therapy, which is relevant to clinicians and patients weighing that treatment's risks. The full article is needed to judge the strength of the findings.
Who’s affected
- ophthalmologists and neurologists
- clinicians prescribing incretin-based therapy
- patients taking incretin-based therapy
- #naion
- #incretin
- #optic-nerve
- #ophthalmology
- #medical-research